Exascale Labs Holdings Inc. XLAB
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.63M | -3.77M | -1.52M | -1.48M | -1.54M |
| Total Depreciation and Amortization | 1.60K | 1.60K | 2.10K | 1.60K | 1.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 495.40K | 2.01M | 910.30K | 898.80K | 991.50K |
| Change in Net Operating Assets | 1.56M | 2.34M | -3.17M | 327.90K | -207.10K |
| Cash from Operations | -573.80K | 587.10K | -3.77M | -252.80K | -751.00K |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 606.80K | -- | -- | -- | -- |
| Cash from Investing | 606.80K | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 1.78M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -45.00K | 0.00 | -50.00K | -- | -- |
| Cash from Financing | -45.00K | 0.00 | -50.00K | 0.00 | 1.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.10K | 587.10K | -3.82M | -252.80K | 1.02M |